China National Medicines Corporation Ltd. (SHA:600511)

SHA:600511 Revenue

China National Medicines Corporation had revenue of 13.75B CNY in the quarter ending September 30, 2025, with 3.58% growth. This brings the company's revenue in the last twelve months to 51.95B, up 1.48% year-over-year. In the year 2024, China National Medicines Corporation had annual revenue of 50.60B with 1.81% growth.

• Revenue (ttm): 51.95B
• Revenue Growth: +1.48%
• P/S Ratio: 0.44
• Revenue / Employee: 16.74M
• Employees: 3,104
• Market Cap: 23.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	50.60B	901.40M	1.81%
Dec 31, 2023	49.70B	4.20B	9.23%
Dec 31, 2022	45.50B	-970.02M	-2.09%
Dec 31, 2021	46.47B	6.09B	15.08%
Dec 31, 2020	40.38B	-4.27B	-9.56%